Literature DB >> 22360819

CHADS2 and CHA2DS2-VASc risk factors to predict first cardiovascular hospitalization among atrial fibrillation/atrial flutter patients.

Gerald V Naccarelli1, Mary Prince Panaccio, Gordon Cummins, Nora Tu.   

Abstract

Limited data exist concerning risk factors for cardiovascular (CV) hospitalization in patients with atrial fibrillation (AF) or atrial flutter (AFL). The aim of this retrospective cohort evaluation was to assess whether patient characteristics and risk factors, including CHADS(2) (congestive heart failure, hypertension, age ≥75 years, type 2 diabetes, and previous stroke or transient ischemic attack [doubled]) and CHA(2)DS(2)-VASc (congestive heart failure; hypertension; age ≥75 years [doubled]; type 2 diabetes; previous stroke, transient ischemic attack, or thromboembolism [doubled]; vascular disease; age 65 to 75 years; and sex category) scores, identified patients with AF or AFL at risk for CV hospitalization. Claims data (January 2003 to June 2009) were evaluated to identify patients aged ≥40 years with ≥1 inpatient or ≥2 (within 30 days of each other) outpatient diagnoses of AF or AFL and an absence of diagnosis codes related to cardiac surgery within 30 days of AF or AFL diagnosis. Risk factors for first CV hospitalization in the 2-year period after diagnosis were assessed using univariate and multivariate analyses. Overall, 377,808 patients (mean age 73.9 ± 12.1 years) were identified, of whom 128,048 had CV hospitalizations. CHADS(2) and CHA(2)DS(2)-VASc scores were the top 2 predictors of first CV hospitalization after AF or AFL diagnosis. Hospitalization risk was increased 2.3- to 2.7-fold in patients with CHADS(2) scores of 6 and approximately 3.0-fold in patients with CHA(2)DS(2)-VASc scores of 9 compared to patients with a score of 0. These increases were maintained essentially unchanged throughout the 2-year follow-up period. In conclusion, CHADS(2) and CHA(2)DS(2)-VASc scores were predictive of first CV hospitalization in patients with AF or AFL and may be helpful in identifying "at-risk" patients and guiding therapy.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22360819     DOI: 10.1016/j.amjcard.2012.01.371

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  24 in total

Review 1.  Current understanding of bleeding with ibrutinib use: a systematic review and meta-analysis.

Authors:  François Caron; Darryl P Leong; Christopher Hillis; Graeme Fraser; Deborah Siegal
Journal:  Blood Adv       Date:  2017-05-09

2.  Clinical Prediction Models for Sleep Apnea: The Importance of Medical History over Symptoms.

Authors:  Berk Ustun; M Brandon Westover; Cynthia Rudin; Matt T Bianchi
Journal:  J Clin Sleep Med       Date:  2016-02       Impact factor: 4.062

3.  Prediction of mortality in patients with implantable defibrillator using CHADS2 score: data from a prospective observational investigation.

Authors:  Giovanni Morani; Domenico Facchin; Giulio Molon; Gabriele Zanotto; Massimiliano Maines; Franco Zoppo; Sakis Themistoclakis; Giuseppe Allocca; Ermanno Dametto; Emanuele Bertaglia; Pietro Turrini; Bruna Bolzan; Alessandro Costa; Alessandro Proclemer; Flavio Luciano Ribichini
Journal:  Am J Cardiovasc Dis       Date:  2018-12-15

4.  CHA2DS2-VASc score predicts short- and long-term outcomes in patients with acute ischemic stroke treated with intravenous thrombolysis.

Authors:  Giovanni Merlino; Michele Rana; Sara Naliato; Iacopo Cancelli; Simone Lorenzut; Roberto Marinig; Roberto Eleopra
Journal:  J Thromb Thrombolysis       Date:  2018-01       Impact factor: 2.300

Review 5.  Anticoagulation in atrial fibrillation with heart failure.

Authors:  Lei Zhao; William Y S Wang; Xinchun Yang
Journal:  Heart Fail Rev       Date:  2018-07       Impact factor: 4.214

Review 6.  Cardiac Resynchronization in Patients with Atrial Fibrillation.

Authors:  S Serge Barold; Bengt Herweg
Journal:  J Atr Fibrillation       Date:  2015-12-31

Review 7.  Ischemic Stroke: Risk Stratification, Warfarin Teatment and Outcome Measure.

Authors:  Srikanth Kaithoju
Journal:  J Atr Fibrillation       Date:  2015-12-31

8.  Risk and outcome after ablation of isthmus-dependent atrial flutter in elderly patients.

Authors:  Béatrice Brembilla-Perrot; Jean Marc Sellal; Arnaud Olivier; Vladimir Manenti; Thibault Villemin; Daniel Beurrier; Christian De Chillou; Zohra Lamiral; Nicolas Girerd
Journal:  PLoS One       Date:  2015-05-22       Impact factor: 3.240

9.  CHA2DS2-VASC score predicts coronary artery disease progression and mortality after ventricular arrhythmia in patients with implantable cardioverter-defibrillator.

Authors:  Refik Kavsur; Marc Ulrich Becher; Welat Nassan; Alexander Sedaghat; Adem Aksoy; Jan Wilko Schrickel; Georg Nickenig; Vedat Tiyerili
Journal:  Int J Cardiol Heart Vasc       Date:  2021-05-25

10.  Left atrial strain as evaluated by two-dimensional speckle tracking predicts left atrial appendage dysfunction in patients with acute ischemic stroke.

Authors:  Shintaro Sasaki; Tetsu Watanabe; Harutoshi Tamura; Satoshi Nishiyama; Masahiro Wanezaki; Chika Sato; Gensai Yamaura; Mitsunori Ishino; Takanori Arimoto; Hiroki Takahashi; Tetsuro Shishido; Takuya Miyamoto; Isao Kubota
Journal:  BBA Clin       Date:  2014-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.